Claudia Cellini

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

Michèle Cavo, Paola Tacchetti, Francesca Patriarca et al. · The Lancet · 2010 · 818 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +10

Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical Study

Michèle Cavo, Patrizia Tosi, Elena Zamagni et al. · Journal of Clinical Oncology · 2007 · 373 citations · Full text

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma

Michèle Cavo, Elena Zamagni, Patrizia Tosi et al. · Blood · 2005 · 365 citations

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

Antonio Palumbo, Michèle Cavo, Elena Zamagni et al. · Journal of Clinical Oncology · 2011 · 320 citations · Full text

The role of positron emission tomography (PET) in the management of lymphoma patients

Pier Luigi Zinzani, Massimo Magagnoli, Franca Chierichetti et al. · Annals of Oncology · 1999 · 180 citations

Positron Emission Tomography, Lymphoid Neoplasia, Oncologic Imaging +7